Once-Daily Protease Inhibitor-Based HAART: Considerations in the Selection of a Regimen in Patients with HIV

This series of 45 national CME-accredited programs is intended to assist physicians, pharmacists, and nurses in understanding how to treat and manage patients with HIV who are receiving once-daily protease inhibitor-based HAART. The meetings extend throughout 2008.

To register for a meeting that is scheduled at your institution, please click